HOME >> BIOLOGY >> NEWS
Small RNA surmounts large cancer problem

Many potentially effective cancer treatments are undone by the onset of resistance to the treatment. In order to circumvent this problem, D. Gary Gilliland and colleagues, of Brigham and Women's Hospital, have developed a strategy using the latest technologies involving small interfering RNA to enhance cancer treatment even in a situation where drug resistance has developed. Small interfering RNAs work by inhibiting the expression of specific genes that have a matching complimentary sequence. The authors theorized that this type of RNA treatment might boost the effectiveness of anti-cancer treatments. They tested their theory in a form of leukemia that is caused when two genes fuse to form an unregulated gene that transforms normal cells into cancer cells, a gene called TEL-PDGFbetaR. This form of leukemia is generally treated with a commonly used anti-cancer drug called imatinib, which is a small molecule protein inhibitor that blocks the activity of the protein produced from the fusion gene TEL-PDGFbetaR. Gilliland and colleagues created a small inhibitory RNA specific to the TEL-PDGFbetaR fusion gene, and found that its expression did indeed exclusively reduce the expression of the oncogenic TEL-PDGFbetaR by 90%. While this alone was not sufficient to kill the cancer cells, this treatment enhanced the ability of imatinib to kill these cancer cells. Further, when they tested this strategy with imatinib-resistant cells, the inhibitory RNA was still able to reduce this gene's expression, and enhanced the activity of another small molecule inhibitor. This study demonstrates that small inhibitory RNA treatment may be an extremely useful adjunct to cancer treatments, and can also aid in overcoming the common problem of drug resistance when used in conjunction with anticancer agents.


'"/>

Contact: Laurie Goodman
press_releases@the-jci.org
212-342-4159
Journal of Clinical Investigation
15-Jun-2004


Page: 1

Related biology news :

1. Small, Smac-like molecule encourages death of cancer cells
2. Small animal imaging gives cancer clues
3. Small, cold, & hungry: Ultra-small microbes from 120,000-year-old glacier ice sample
4. Small trial shows daclizumab add-on therapy improves MS outcome
5. Small gene changes in some leukemia patients may explain varying responses to chemotherapy
6. Small amounts of alcohol or anesthetics may damage the developing brain
7. Smallpox in 50-year-old tissues detected by integrated diagnostics approach
8. Small-molecule inhibitors of anthrax lethal factor identified
9. Smallpox in Europe selected for genetic mutation that confers resistance to HIV infection
10. Small-molecule inhibitors of botulinum neurotoxin identified
11. Smallest whirlpools can pack stunningly strong force

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/6/2019)... ... 2019 , ... Ziegler, a specialty investment bank, is pleased ... (PBM) on its recent acquisition by PathGroup. , Headquartered in Lewisville (Dallas), ... than one dozen hospitals and surgery centers in the Dallas-Fort Worth and broader ...
(Date:6/4/2019)... ... ... Harper was three years old when her owners took her to the ... osteoarthritis in the joints. She was referred to a veterinary specialist to perform ... Dr. Christopher Eich of Southern California Veterinary Specialty Hospital , examined Harper and ...
(Date:6/3/2019)... (PRWEB) , ... June 03, 2019 , ... Stay on ... biotech, medical device and food industries. Access to all webinars is free, so be ... relevant in your field! , Visit http://www.xtalks.com to see our upcoming webinars: ...
Breaking Biology News(10 mins):
(Date:5/7/2019)... ... May 06, 2019 , ... ... for the growing number of repositories being asked to store cellular products ... the team of contributors who are world leaders, who have shared their expertise ...
(Date:5/2/2019)... (PRWEB) , ... April 30, ... ... the International Organization for Standardization ISO 9001:2015 standard, REPROCELL USA Inc. has ... customer requirements. In addition, REPROCELL USA Inc. aims to enhance customer satisfaction ...
(Date:5/2/2019)... VIEJO, Calif. (PRWEB) , ... May 02, 2019 ... ... leading clinical genetics testing company, will present results documenting discrepancies between U.S. insurer ... management guidelines for patients at risk for hereditary breast and ovarian cancer (HBOC). ...
(Date:4/25/2019)... ... April 24, 2019 , ... ... sales and service organizations, today announced global availability of Inference Studio’s latest version, ... of all sizes to harness the power of Google’s Contact Center AI ...
Breaking Biology Technology:
Cached News: